MG - Molecules-27-05529
MG - Molecules-27-05529
MG - Molecules-27-05529
Review
Applications of Biodegradable Magnesium-Based Materials in
Reconstructive Oral and Maxillofacial Surgery: A Review
Sanja Vujović 1 , Jana Desnica 1 , Dragana Stanišić 1 , Irena Ognjanović 1 , Momir Stevanovic 1, *
and Gvozden Rosic 2, *
1 Department of Dentistry, Faculty of Medical Sciences, University of Kragujevac, Svetozara Markovića 69,
34000 Kragujevac, Serbia
2 Department of Physiology, Faculty of Medical Sciences, University of Kragujevac, Svetozara Markovića 69,
34000 Kragujevac, Serbia
* Correspondence: momirstevanovic7@gmail.com (M.S.); grosic@medf.kg.ac.rs (G.R.);
Tel.: +381-641-327752 (M.S.); +381-633-92812 (G.R.)
Abstract: Reconstruction of defects in the maxillofacial region following traumatic injuries, cranio-
facial deformities, defects from tumor removal, or infections in the maxillofacial area represents a
major challenge for surgeons. Various materials have been studied for the reconstruction of defects
in the maxillofacial area. Biodegradable metals have been widely researched due to their excellent
biological properties. Magnesium (Mg) and Mg-based materials have been extensively studied for
tissue regeneration procedures due to biodegradability, mechanical characteristics, osteogenic capac-
ity, biocompatibility, and antibacterial properties. The aim of this review was to analyze and discuss
the applications of Mg and Mg-based materials in reconstructive oral and maxillofacial surgery in
the fields of guided bone regeneration, dental implantology, fixation of facial bone fractures and soft
tissue regeneration.
Citation: Vujović, S.; Desnica, J.;
Stanišić, D.; Ognjanović, I.; Keywords: magnesium; biodegradable metals; maxillofacial surgery; guided bone regeneration;
Stevanovic, M.; Rosic, G. bone fracture
Applications of Biodegradable
Magnesium-Based Materials in
Reconstructive Oral and
Maxillofacial Surgery: A Review. 1. Introduction
Molecules 2022, 27, 5529. https://
Reconstruction of defects in the maxillofacial region following traumatic injuries,
doi.org/10.3390/molecules27175529
craniofacial deformities, defects from tumor removal or infections in the maxillofacial area
Academic Editor: Xiaoying Wang represents a major challenge for surgeons. The maxillofacial region has a significant impact
on patients’ well-being, and any facial deformity or dysfunction has a devastating effect on
Received: 25 July 2022
the patients’ quality of life [1,2]. Reconstruction or augmentation of craniofacial bones is one
Accepted: 25 August 2022
of the most frequent surgical procedures in maxillofacial surgery. After blood transfusion,
Published: 28 August 2022
bone grafting is the second-most common tissue transplantation procedure worldwide [3].
Publisher’s Note: MDPI stays neutral Extensive clinical research on bone grafting and augmentation with autografts, allografts
with regard to jurisdictional claims in and xenografts has been performed. Autografts taken from the same patient are considered
published maps and institutional affil- the gold standard for bone reconstruction, since no immune reaction is expected. However,
iations.
the need for additional surgical intervention, donor site morbidity, limited bone availability
and significant graft resorption emphasized the need for different bone substituents [4,5].
Allografts taken from genetically non-identical members of the same species carry the risk
of pathogen transfer and immune system rejection [6]. Xenografts, usually bovine-derived,
Copyright: © 2022 by the authors.
Licensee MDPI, Basel, Switzerland.
are most often used to augment intraoral bone defects [7]. However, the application of
This article is an open access article
animal-derived materials to humans has certain limitations concerning patients’ religion,
distributed under the terms and dietary restrictions and ethical controversy [7]. To overcome these drawbacks, extensive
conditions of the Creative Commons research on bone tissue engineering using bio-mimicking, resorbable and biocompatible
Attribution (CC BY) license (https:// bone substitutes has been performed in the past years. These synthetic bone substitutes
creativecommons.org/licenses/by/ serve as an artificial extracellular matrix to promote bone healing until they are partially or
4.0/). completely replaced by newly formed bone [8,9]. Biodegradable polymers are extensively
studied as bone scaffolds and have proven osteoconductive properties as well as excellent
biocompatibility [8,9]. However, low mechanical strength, unstable rates of degradability
and immune reaction to products of polymer degradation limit their use in clinical prac-
tice [10]. Titanium (Ti) is the most commonly used non-biodegradable metal in maxillofacial
surgery for stabilization of fractures or osteotomies, dental implantation procedures and
guided bone regeneration (GBR). However, Ti-based materials are bioinert, and secondary
surgical intervention is often needed to remove the Ti materials from the organism mainly
due to discomfort or surgical site infection, which may occur in up to 33% of cases [11].
Biodegradable metals have been extensively studied for tissue regeneration procedures
due to their biodegradability, mechanical properties, osteogenic capacity, biocompatibility
and antibacterial properties [12]. Magnesium (Mg)-based materials have been used in
medicine since the 19th century. Mg is an essential metal for the human organism, and
it is involved in more than 300 cell enzymatic reactions, mitochondrial activity, protein
translation, DNA synthesis and cell proliferation [13]. About 60% of Mg in a healthy adult
is deposited in bones [13]. Mg is resorbed from the intestines, and its homeostasis in the
organism depends on renal function [13]. Due to its mechanical properties, an elastic
modulus similar to human bones and its biosafety, Mg had been used in orthopedic surgery
in the early 20th century until it was replaced with Ti materials [14,15]. The elastic modulus
of Mg is about 45 GPa which is much closer to that of cortical bone (10–23 GPa) compared
to Ti [16]. The development of bioresorbable Mg-based materials prevents the need for
second-stage surgery for the removal of implanted material and associated comorbidities.
The aim of this review is to analyze and discuss the applications of Mg and Mg-
based materials in reconstructive oral and maxillofacial surgery. The review is divided
into subheadings about the use of Mg-based material in: (a) GBR, (b) dental implant
coatings, (c) immobilization of facial bone fractures, and d) soft tissue regeneration. Based
on the literary data, we will discuss possibilities and directions for future development and
applications of Mg-based materials in oral and maxillofacial surgery.
Based on polymers
1. Advantages: biocompatibility,
easy manipulation
2. Disadvantages: poor
mechanical stability, fast
degradation, inflammatory
reaction
Resorbable
membranes
Magnesium-based materials
1. Advantages: biocompatibility,
elastic modulus, osteoinduction,
biodegradation
GBR membranes 2. Disadvantages: uncontrolled
degradation rate
Titanium
1. Advantages: biocompatibility,
Non-resorbable mechanical properties
membranes 2. Disadvantages: need for second
stage surgery
Figure 1. Guided bone regeneration membranes (GBR) for bone tissue regeneration.
Figure 1. Guided bone regeneration membranes (GBR) for bone tissue regeneration.
In Resorbable membranes
order to decrease are widely
the process used due to various
of degradation, their economic
coatingsbenefits, biocompati-
to Mg materials
bility and easy manipulation. However, these membranes
were added. In an in vitro–in vivo study on the critical-sized defect of rabbit calvaria,are often deformed due tothe
rapid
degradation, which may impair bone regeneration,
Mg-Zn-Gd membrane coated with calcium-phosphate (Ca-P) showed superior osteogenicwhile their low mechanical strength
andmakes them unsuitable
mechanical for larger bone
properties compared to thedefects
non-coated[29]. Mg-Zn-Gd
On the other hand, the[35].
membrane application
Surface of
non-resorbable
modification using membranes impliesoxidation
plasma electrolytic the needand forhydrothermal
second-stagetreatmentsurgery. on Biomembranes
Mg mesh
with Mg-based
resulted in decreased materials could combine
degradation and better thequality
mechanicalof newly strength
formed of metallic
bone in alloys,
calvariabio-
compatibility
defects and an
in rats during slow degradation
in vivo experiment in natural tissueshybrid
[36]. Complex as a promising
membranesolutionAZ31-PLGA- for this
demineralized bone matrix (DBM) had a strong ability to promote the proliferation of bone to
problem. Furthermore, the mechanical properties of Mg alloys allow the membrane
maintain
marrow stemthe space
cells and for osteogenesis
resulted in excellent andrepair
bone height in alveolar sockets
of the critical-sized calvariaordefect
largemodel,
bone de-
fects [30].
reported by inThe good
vivo plasticity
research [37]. of
A Mg alloys
similar is usefulvivo
in vitro–in in handling and adapting
study showed that themembranes
addition
to complex
of pure shapes
Mg particles of bony
to the PLGAdefects
scaffold[31]. In addition,
in order to overcome the antibacterial
the low mechanicalproperties of Mg
strength
alloys reduce
of PLGA resultedthe inrisk of bacterial
significant infection of
proliferation and bone resorption
BMSCs [32]. increased bone
and significantly
formation Reports on thepremolar
in a canine clinical application
tooth socketof[38]. Mg-based GBR membranes are scarce due to
Composite
difficulties in Mg-polymer
adapting theirmembranes
degradation and ratematerials
to clinical showed promising
expectations. results
A recent in in
vivo
bone repair.
study Photo-cross-linkable
evaluated the Mg-alloy GBR collagen/polycaprolactone
membrane (Mg-2Zn-0.46Y-0.5Nd) methacryloyl/magnesium
for bone healing in
(Col/PCLMA/Mg) composite bone
a critical-sized mandibular membranes demonstrated
defect within a study excellent
with beagle mechanical
dogs [33]. properties
The results
andofelastic modulus,
this research biocompatibility,
showed and promoted
good biocompatibility, cell attachment
osteoconduction andand osteoprogeni-
osteogenic potential
torofcell
theproliferation
membrane. when However, implanted
the authorsinto calvaria
observed bone
almostdefects of ratspostoperative
complete for 8 weeks in an
resorp-
in vitro–in
tion of thevivomembrane
study [39].within 3 months, which led to reduced osteogenic effect in later
phases. Similarly, the results of the in vivo study with a mineralized collagen/Mg–Ca alloy
3.2.combined
Mg-Based scaffold
Scaffolds designed
for GBR to withstand the physiological forces in the mouth did not
Bone tissue
achieve is a natural
the desired composite
restoration mixture
of alveolar of organic
bone defects in (collagen
dogs [34].fibers) and inorganic
substances (hydroxyapatite
In order to decreasecrystals)
the process [2]. Composite
of degradation, scaffolds
variouscombining
coatingsthe toadvantages
Mg materials
of biodegradable polymers such as PLGA and PEI with hydroxyapatite
were added. In an in vitro–in vivo study on the critical-sized defect of rabbit calvaria, (HA) ceramicsthe
have been extensively studied because they resemble the
Mg-Zn-Gd membrane coated with calcium-phosphate (Ca-P) showed superior osteogenic natural bone structure, and its
mechanical and osteoconductive properties are enhanced by
and mechanical properties compared to the non-coated Mg-Zn-Gd membrane [35]. Sur- a thin biodegradable polymer
coating [4]. In vivo studies
face modification with composite
using plasma electrolytic HA–polymer
oxidation and scaffolds resulted
hydrothermal in complete
treatment on Mg
repair of a critical-sized defect in rabbit’s calvaria, a large
mesh resulted in decreased degradation and better quality of newly formed bone defect of rabbit’s ulna, as wellin acal-
critical
variasize mandibular
defects defect in
in rats during answine
in vivo [2,4,40].
experimentHowever, [36].due to the insufficient
Complex hybrid membrane mechanical
AZ31-
properties of composite bone scaffolds, deformation and brittle
PLGA-demineralized bone matrix (DBM) had a strong ability to promote the proliferation fracture may occur [41]. For
Molecules 2022, 27, 5529 5 of 17
this reason, Mg-based materials with excellent biocompatibility and mechanical properties
were incorporated into HA to enhance their biological and physicochemical properties.
In vitro and in vivo experiments demonstrated significantly improved HA properties with
the addition of Mg [42]. The addition of Mg to HA resulted in improved chemical prop-
erties compared to stoichiometric HA, such as reduced crystallinity, high specific surface
area, and enhanced solubility in natural tissues. These factors lead to improved cell adhe-
sion, proliferation, and metabolic activity [43]. A mixture of HA and β-TCP doped with
Mg (magnesium-doped biphasic calcium phosphate) mimics the natural inorganic bone
matrix with excellent physicochemical properties [44]. Furthermore, the presence of Mg
ions during synthesis also improves the thermal stability of HA and produces a more
stable phase composition after heat treatment, which enables the production of porous or
granulated scaffolds for biomedical applications, including oral and maxillofacial surgery
and orthopedics [44,45]. Magnesium Hydroxyapatite (MgHA) scaffold was analyzed for
bone regeneration in alveolar critical-sized bone defects in several animal and human trials.
The results suggest that the MgHA scaffold could be a very effective bone substitute [46].
Various in vitro studies reported excellent biocompatibility for several cell lines [47–49].
Sartori et al. demonstrated in an in vivo study conducted on sheep that MgHA provides
osteoconductive structural support during the process of bone regeneration [50]. Santos
et al. concluded in an in vivo experiment that MgHA, when implanted in a critical bone
defect in rat calvaria, is a biocompatible and osteoconductive biomaterial [51]. A clinical
study by Grigolato et al. showed that MgHA, used as a bone substitute in a mandibular de-
fect due to ameloblastoma, exhibits excellent biological behavior and high osseointegration
potential [52]. MgHA is a relatively well-studied Mg-based bone substitute material, and
there are several commercial products researched for the reconstruction of maxillofacial
bone defects.
Teeth extractions cause significant changes in the dimensions of the alveolar ridge due
to resorption of the alveolar socket, which may impair dental implantation and prosthetic
reconstruction [53]. Resorption of the alveolar socket is rapid following tooth extraction
due to loss of function, and about 40–60% of bone is resorbed in the first two years [54]. The
preservation of the alveolar socket volume following tooth extractions and alveolar ridge
preservation or augmentation could be achieved using MgHA scaffolds. In a clinical study
by Crespo et al. a split-mouth design was used to compare histologic and histomorphomet-
ric results of MgHA and porcine bone grafts for the preservation of fresh dental sockets [55].
The results of this study showed similar biologic behavior in bone formation and resorption
processes. A similar clinical study that compared radiographic and histomorphometric
results of MgHA and calcium sulfate grafts in fresh sockets after tooth extractions found
a lower reduction of the alveolar ridge, more bone formation and more residual implant
material in the MgHA group [56].
A prospective 2-year clinical study evaluated the survival of dental implants loaded
14 weeks after vertical alveolar ridge augmentation with nano-structured MgHA covered
with Ti-polytetrafluoroethylene (e-PTFE) membrane [54]. The results of this study sug-
gested that vertical ridge augmentation around Ti implants using MgHA can be successful
in cases with early implant loading. However, an in vivo animal study with canines did
not find a significant effect of MgHA on alveolar socket preservation and osseointegration
of implants placed immediately into extraction sockets [57]. Recently, a clinical study
investigated the effectiveness of a biomimetic MgHA/collagen-based bone substitute for
alveolar socket preservation compared to deproteinized bovine bone matrix [58]. The
results after 6 months showed similar vertical and horizontal alveolar ridge resorption,
similar new bone formation between the groups and a significantly higher residual material
for deproteinized bovine bone matrix. Crespo et al. compared the use of MgHA and autol-
ogous bone graft for maxillary sinus lift procedures [59]. The results of this clinical study
suggested MgHA as a possible alternative to autologous bone graft for sinus lift operations.
There are promising results from using bovine bone grafts enriched with Mg for
bone regeneration. An in vivo study on the biological properties of bovine xenogeneic
Molecules 2022, 27, 5529 6 of 17
biomaterial enriched with Mg on the healing of critical-sized defects on rat calvaria showed
Mg biomaterial demonstrated osteoinductive properties and biodegradability during heal-
ing [60]. Similar results were reported for the rabbit calvaria defect repair in an in vivo
study [61].
Mg-based bone types of cement have been used in orthopedics for bone and tendon
repair [62]. The results of canine in vivo study that evaluated Mg-based bone cement for
bone grafting of immediate implantation of extraction sockets showed success at filling in
the bone defects without implant loss during the observation period [63]. However, the
use of Mg-based bone types of cement may be doubtful due to their 3D structure and lack
of porosity, which enables osteoconductive properties [10].
Zhang et al. developed 3D gel printing in an in vitro–in vivo study and used it to
prepare an Mg scaffold with a controllable pore structure, and its surface was modified
with a calcium phosphate coating [41]. The addition of calcium phosphate coating onto
the surface of materials improved biocompatibility and biosafety, osteogenic induction
and angiogenic ability; in addition, the degradation rate of materials can be effectively
controlled by adjusting the thickness of calcium phosphate coating [64].
because most of the surgical interventions are performed through an intraoral approach,
with different elastic modules of facial bones as well as various shapes of bones [80,97].
Biodegradable polymer fixation plates made from PLLA and PLGA have poor mechanical
properties and may cause an inflammatory reaction [98]. Mg-based materials possess good
mechanical strength and biocompatibility with proven clinical applications. However, the
compressive yield strength of Mg-based alloys is lower than Ti alloys which questions their
use for load-bearing fractures such as mandible fractures [99]. Pre-clinical studies revealed
Mg-based materials as promising candidates for maxillofacial bone osteosynthesis [99–110]
(Table 1).
Mandibular fractures are the most common fractures in the maxillofacial area, and
their treatment consists of thick Ti plates and locking screws to restore the bone’s anatomical
shape along with occlusion, and avoid postoperative movement of the fragments by heavy
masticatory forces [102]. Only one animal study by Nujokat et al. used MgYZrRee (WE43)
custom-made fixation plates and screws for the stabilization of mandibular osteotomy
at the mandibular angle [103]. The results of this in vivo study proved good mechanical
stability at the osteotomy site. However, the performed osteotomy was monocortical and
did not represent a full bicortical fracture line. Mg screws were investigated in several
studies and reported better mechanical properties compared to the polymeric material
but lower mechanical and torsional strength than Ti controls [98–100]. Interesting are the
results of Mg screws for stabilization of osteotomy lines for bilateral ramus sagittal split
osteotomy (BSSO) performed for orthognathic surgery procedures where the mandibular
setback or advance is performed to correct maxillofacial deformities. The results of two
studies based on finite element modeling found the use of Mg or Mg-Ca-Zn screws could
stabilize the osteotomy lines even with masticatory loading [100,101]. Further pre-clinical
and clinical trials are needed in order to obtain an Mg-based fixation system for mandible
fractures and osteotomies to overcome current disadvantages regarding mechanical stress
and low torsional strength.
On the other hand, the results of animal studies on the fixation of the midface complex
fractures are more promising. Midface fractures, mainly fractures of the maxilla and
zygomatic bone, are load-shearing types of fractures where no significant masticatory
forces are implied to reduce the stability of the fracture line. The use of WE43 plates and
screws for the fixation of fractures in the midface resulted in good osteotomy lines stability,
biocompatibility, and osseointegration [103–106]. The gas formation was observed for
12 weeks postoperatively without side effects on bone regeneration and wound healing,
proposing that the material’s degradation rate is adequate. The use of PLLA-coated ZK60
plates and screws for fixation of Le Fort I osteotomy in beagles resulted in significant gas
formation and local inflammation due to the fast biodegradation of the material [107].
Although ZK60 plates showed good mechanical properties, it seemed that PLLA coating
failed to prevent the rapid absorption of the alloy due to micro-cracks on the surface [107].
Further research is needed to obtain alloys with more predictable rates of biodegradation
and mechanical properties for these types of fractures. Fixation systems based on Mg
materials used in these studies were thicker and had a bigger volume compared to Ti
fixation systems, although there was no significant discomfort to the subjects
Promising results of pre-clinical studies have been published regarding the use of
WE43 plates and screws for the fixation of fractures in the frontal bone [108,109]. The
stability of the plates and biocompatibility were comparable to the Ti fixation system.
The repair of orbital fractures represents a significant challenge to the surgeons due
to the proximity of intracranial structures, paranasal sinuses, the poor blood supply of
the bones and osteoprogenitor cell insufficiency [110]. The thin bony walls of the orbit,
especially the inferior and medial walls, are the most prominent locations for fractures.
Blow-out fractures of the orbital floor are the most common fracture of the orbit. Current
materials used for fracture reduction and reconstruction of the orbital volume are bioinert
Ti meshes, plates, and polyethylene meshes. Zhang et al. developed Ca-P coated Mg-Zn-Gd
scaffold to reconstruct a large defect of the medial orbital wall in a canine model [110]. The
results showed excellent osteoconductivity, angiogenesis and bone regeneration with the
scaffold. The authors observed no gas formation and orbital emphysema.
Only two clinical studies by Leonhardt et al. reported the effectiveness of Mg-based
materials for the treatment of fractures in maxillofacial surgery [111,112]. These studies
reported repositioning and fixation of mandibular condyle fracture with Magnezix® CS
2.7 mm screw (MgYREZr alloy). The authors reported excellent stabilization of fragments
and complete restoration of temporomandibular joint (TMJ) function. Gas formation
around screws was reported and seen as radiolucent areas on control CBCT exams. One
year follow-up was uneventful, and there was no need for screw removal (Table 2).
Molecules 2022, 27, 5529 10 of 17
Table 2. Clinical studies on magnesium (Mg)-based material for stabilization of fracture of the
mandibular condyle.
In addition, the trauma to the peripheral motoric branches of the facial nerve during
parotid gland surgery or mastoidectomy can result in facial paralysis. Restoring the function
of motor nerves is much more difficult and uncertain compared to sensory nerves [128].
Gougoulias et al. reported in an in vivo study that subcutaneous injection of Mg in neonatal
rats reduced motor neuron death after sciatic nerve axotomy [129]. In vitro studies showed
Mg ions could promote the proliferation of neural stem cells [130]. Further studies are
needed to evaluate the role of Mg in sensory and motor nerve repair.
Table 3 summarizes application areas of Mg-based materials in reconstructive oral and
maxillofacial surgery.
Study
Application Advantages Disadvantages Future Directions
In vitro In vivo Clinical
Mandible -biocompatibility -low resistance to -improvement of
+ + +
fracture -degradation masticatory stress mechanical resistance for
Fracture Midface -elastic modulus -uncontrolled load-bearing fractures
reduction + + − -mechanical properties -development of Mg
fracture degradation rate
-no second alloys with predictive
Frontal bone stage surgery -uncontrolled degradation rate
+ + −
fracture degradation rate
-biocompatibility
-osteoconductivity -improvement of 3D
Scaffolds + + + -low porosity
-bone repair porosity
-biocompatibility
GBR
-degradation-
mechanical properties -improvement of
-uncontrolled
Membrane + + − -osteogenic effect mechanical properties
degradation rate
-small and large and degradation rate
bone defects
-antibacterial activity
-biocompatibility
-need for clinical trials
-degradation-
-development of
Oral implantology + + − osteoblastic -degradation rate
techniques for
differentiation
Mg coating
-antibacterial activity
-no trials on the possible
-protective effect -no data on
TMJ + − − use on TMJ
on cartilage TMJ regeneration
cartilage regeneration
-no trials on the
Dental pulp + − − -dental pulp repair
Soft tissue preclinical or clinical use
regeneration -fibroblast activation
-possible use in
Oral mucosa + − − -mucosa regeneration
dental implantology
-antibacterial properties
-possible use in sensitive
Nerve tissue + + − -nerve regeneration
nerve neuropathy
GBR—Guided bone regeneration; TMJ—Temporomandibular joint.
7. Conclusions
Mg-based materials have been extensively studied for their use in biomedicine in the
past decade. Mg-based materials represent a very promising group of biomaterials for
application in reconstructive medicine. Mg has an essential role in cell metabolism, and it
is involved in more than 300 enzymatic processes. Mg-based materials are biodegradable,
biocompatible, with elastic modulus similar to that of bone and with a positive effect
on bone regeneration. In the field of reconstructive oral and maxillofacial surgery, its
positive effects were reported in the areas of guided bone regeneration, improvement
of dental implant osseointegration, fixation of facial bone fractures and regeneration of
soft tissues. Due to the positive effect on bone repair and differentiation of osteoblasts,
Molecules 2022, 27, 5529 12 of 17
Mg-based materials were successfully evaluated in clinical studies for guided regeneration
of jaw bones. In vitro and in vivo studies reported improved osseointegration when Mg
coating was applied to the Ti implant surface. Clinical studies on the application of Mg-
based materials for the treatment of maxillofacial fractures have been published, and
further research is needed to develop the Mg alloy with adequate mechanical strength
and degradation rate. Further research is still needed to improve the characteristics of
Mg-based materials for application in the maxillofacial area.
Author Contributions: Conceptualization, S.V. and G.R.; writing—original draft preparation, S.V.,
J.D., D.S., I.O. and M.S.; writing—review and editing, S.V. and G.R.; supervision, M.S. and G.R. All
authors have read and agreed to the published version of the manuscript.
Funding: This research received no external funding.
Institutional Review Board Statement: Not applicable.
Informed Consent Statement: Not applicable.
Data Availability Statement: Not applicable.
Conflicts of Interest: The authors declare no conflict of interest.
References
1. Probst, F.A.; Fliefel, R.; Burian, E.; Probst, M.; Eddicks, M.; Cornelsen, M.; Riedl, C.; Seitz, H.; Aszódi, A.; Schieker, M.; et al.
Bone regeneration of minipig mandibular defect by adipose derived mesenchymal stem cells seeded tri-calcium phosphate-
poly(D,L-lactide-co-glycolide) scaffolds. Sci. Rep. 2020, 10, 2062. [CrossRef] [PubMed]
2. Stevanovic, M.; Selakovic, D.; Vasovic, M.; Ljujic, B.; Zivanovic, S.; Papic, M.; Zivanovic, M.; Milivojevic, N.; Mijovic, M.;
Tabakovic, S.; et al. Comparison of hydroxyapatite/poly(lactide-co-glycolide) and hydroxyapatite/polyethyleneimine composite
scaffolds in bone regeneration of swine mandibular critical size defects: In vivo study. Molecules 2022, 16, 1694. [CrossRef]
[PubMed]
3. Herber, V.; Okutan, B.; Antonoglou, G.; Sommer, N.G.; Payer, M. Bioresorbable magnesium-based alloys as novel biomaterials in
oral bone regeneration: General review and clinical perspectives. J. Clin. Med. 2021, 10, 1842. [CrossRef] [PubMed]
4. Jokanović, V.; Čolović, B.; Marković, D.; Petrović, M.; Soldatović, I.; Antonijević, D.; Milosavljević, P.; Sjerobabin, N.; Sopta, J.
Extraordinary biological properties of a new calcium hydroxyapatite/poly(lactide-co-glycolide)-based scaffold confirmed by
in vivo investigation. Biomed. Eng. Biomed. Tech. 2017, 62, 295–306. [CrossRef]
5. Arrington, E.D.; Smith, W.J.; Chambers, H.G.; Bucknell, A.L.; Davino, N.A. Complications of iliac crest bone graft harvesting.
Clin. Orthop. Relat. Res. 1996, 329, 300–309. [CrossRef]
6. Boyce, T.; Edwards, J.; Scarborough, N. Allograft bone. The influence of processing on safety and performance. Orthop. Clin. 1999,
30, 571–581. [CrossRef]
7. Sheikh, Z.; Hamdan, N.; Ikeda, Y.; Grynpas, M.; Ganss, B.; Glogauer, M. Natural graft tissues and synthetic biomaterials for
periodontal and alveolar bone reconstructive applications: A review. Biomater. Res. 2017, 21, 9. [CrossRef]
8. Karadžić, I.; Vučić, V.; Jokanović, V.; Debeljak-Martačić, J.; Marković, D.; Petrović, S.; Glibetić, M. Effects of novel hydroxyapatite-
based 3D biomaterials on proliferation and osteoblastic differentiation of mesenchymal stem cells. J. Biomed. Mater. Res. Part A
2015, 103, 350–357. [CrossRef]
9. Liu, L.; Shi, G.; Cui, Y.; Li, H.; Li, Z.; Zeng, Q.; Guo, Y. Individual construction of freeform-fabricated polycaprolactone scaffolds
for osteogenesis. Biomed. Eng. Biomed. Tech. 2017, 62, 467–479. [CrossRef]
10. Xia, D.; Yang, F.; Zheng, Y.; Liu, Y.; Zhou, Y. Research status of biodegradable metals designed for oral and maxillofacial
applications: A review. Bioact. Mater. 2021, 6, 4186–4208. [CrossRef]
11. Cousin, A.S.; Bouletreau, P.; Giai, J.; Ibrahim, B.; Louvrier, A.; Sigaux, N. Severity and long-term complications of surgical site
infections after orthognathic surgery: A retrospective study. Sci. Rep. 2020, 10, 12015. [CrossRef] [PubMed]
12. Zheng, Y.F.; Gu, X.N.; Witte, F. Biodegradable metals. Mater. Sci. Eng. 2014, 77, 1–34. [CrossRef]
13. Saris, N.E.; Mervaala, E.; Karppanen, H.; Khawaja, J.A.; Lewenstam, A. Magnesium. An update on physiological, clinical and
analytical aspects. Clin. Chim. Acta 2000, 294, 1–26. [CrossRef]
14. Witte, F. The history of biodegradable magnesium implants: A review. Acta Biomater. 2010, 6, 1680–1692. [CrossRef] [PubMed]
15. Hang, R.; Wang, C.; Yu, Z.; Li, Z.; Xiao, Y. Biodegradable metallic wires in dental and orthopedic applications: A review. Metals
2018, 8, 212. [CrossRef]
16. Rider, P.; Kačarević, Ž.P.; Elad, A.; Rothamel, D.; Sauer, G.; Bornert, F.; Windisch, P.; Hangyási, D.; Molnar, B.; Hesse, B.; et al.
Biodegradation of a magnesium alloy fixation screw used in a guided bone regeneration model in Beagle dogs. Materials 2022,
15, 4111. [CrossRef] [PubMed]
17. Weng, L.; Webster, T.J. Nanostructured magnesium increases bone cell density. Nanotechnology 2012, 23, 485105. [CrossRef]
Molecules 2022, 27, 5529 13 of 17
18. Weng, L.; Webster, T.J. Nanostructured magnesium has fewer detrimental effects on osteoblast function. Int. J. Nanomed. 2013,
8, 1773. [CrossRef]
19. Glenske, K.; Donkiewicz, P.; Köwitsch, A.; Milosevic-Oljaca, N.; Rider, P.; Rofall, S.; Franke, J.; Jung, O.; Smeets, R.;
Schnettler, R.; et al. Applications of metals for bone regeneration. Int. J. Mol. Sci. 2018, 19, 826. [CrossRef]
20. Yoshizawa, S.; Brown, A.; Barchowsky, A.; Sfeir, C. Magnesium ion stimulation of bone marrow stromal cells enhances osteogenic
activity, simulating the effect of magnesium alloy degradation. Acta Biomater. 2014, 10, 2834–2842. [CrossRef]
21. Li, Y.; Wang, J.; Yue, J.; Wang, Y.; Yang, C.; Cui, Q. High magnesium prevents matrix vesicle-mediated mineralization in human
bone marrow-derived mesenchymal stem cells via mitochondrial pathway and autophagy. Cell Biol. Int. 2018, 42, 205–215.
[CrossRef] [PubMed]
22. Tsao, Y.T.; Shih, Y.Y.; Liu, Y.A.; Liu, Y.S.; Lee, O.K. Knockdown of SLC41A1 magnesium transporter promotes mineralization and
attenuates magnesium inhibition during osteogenesis of mesenchymal stromal cells. Stem Cell Res. Ther. 2017, 8, 39. [CrossRef]
[PubMed]
23. Nakatani, S.; Mano, H.; Ryanghyok, I.; Shimizu, J.; Wada, M. Excess magnesium inhibits excess calcium-induced matrix-
mineralization and production of matrix gla protein (MGP) by ATDC5 cells. Biochem. Biophys. Res. Commun. 2006, 348, 1157–1162.
[CrossRef] [PubMed]
24. Torroni, A.; Xiang, C.; Witek, L.; Rodriguez, E.D.; Coelho, P.G.; Gupta, N. Biocompatibility and degradation properties of WE43
Mg alloys with and without heat treatment: In vivo evaluation and comparison in a cranial bone sheep model. J. Cranio-Maxillofac.
Surg. 2017, 45, 2075–2083. [CrossRef]
25. Wang, J.; Xu, J.; Liu, W.; Li, Y.; Qin, L. Biodegradable magnesium (Mg) implantation does not impose related metabolic disorders
in rats with chronic renal failure. Sci. Rep. 2016, 6, 26341. [CrossRef] [PubMed]
26. Amukarimi, S.; Mozafari, M. Biodegradable magnesium biomaterials-road to the clinic. Bioengineering 2022, 5, 107. [CrossRef]
27. He, Y.; Tao, H.; Zhang, Y.; Jiang, Y.; Zhang, S.; Zhao, C.; Li, J.; Zhang, B.; Song, Y.; Zhang, X. Biocompatibility of bio-Mg-Zn alloy
within bone with heart, liver, kidney and spleen. Chin. Sci. Bull. 2009, 54, 484–491. [CrossRef]
28. Luthringer, B.J.; Feyerabend, F.; Willumeit-Römer, R. Magnesium-based implants: A mini-review. Magnes. Res. 2014, 27, 142–154.
[CrossRef]
29. Pilipchuk, S.P.; Plonka, A.B.; Monje, A.; Taut, A.D.; Lanis, A.; Kang, B.; Giannobile, W.V. Tissue engineering for bone regeneration
and osseointegration in the oral cavity. Dent. Mater. 2015, 31, 317–338. [CrossRef]
30. Ge, J.; Yang, C.; Wang, Y.; Zheng, J.; Hua, H.; Zhu, J. Comparison of different grafting materials for treatment of bone defect distal
to the molar in canine. Clin. Implant Dent. Relat. Res. 2018, 20, 444–454. [CrossRef]
31. Barbeck, M.; Kuhnel, L.; Witte, F.; Pissarek, J. Degradation, bone regeneration and tissue response of an innovative volume stable
magnesium-supported GBR/GTR barrier membrane. Int. J. Mol. Sci. 2020, 9, 3098. [CrossRef] [PubMed]
32. Zhao, C.; Hou, P.; Ni, J.; Han, P.; Chai, Y.; Zhang, X. Ag- incorporated FHA coating on pure Mg: Degradation and in vitro
antibacterial properties. ACS Appl. Mater. Interfaces 2016, 8, 5093–5103. [CrossRef] [PubMed]
33. Yan, Z.Y.; Zhu, J.H.; Liu, G.Q.; Liu, Z.C.; Guo, C.B.; Cui, N.H.; Han, J.M. Feasibility and efficacy of a degradable magnesium-alloy
GBR membrane for bone augmentation in a distal bone-defect model in Beagle dogs. Bioinorg. Chem. Appl. 2022, 2022, 4941635.
[CrossRef] [PubMed]
34. Guo, C.W.; Yu, Q.; Sun, B.Z.; Wang, C.Y.; Yang, J.X. Evaluation of alveolar bone repair with mineralized collagen block reinforced
with Mg–Ca alloy rods. J. Biomater. Tissue Eng. 2018, 8, 1–10. [CrossRef]
35. Si, J.; Shen, H.; Miao, H.; Tian, Y.; Huang, H.; Shi, J.; Shen, G. In vitro and in vivo evaluations of Mg-Zn-Gd alloy membrane on
guided bone regeneration for rabbit calvarial defect. J. Magnes. Alloy. 2021, 9, 281–291. [CrossRef]
36. Wu, S.; Jang, Y.S.; Kim, Y.K.; Kim, S.Y.; Ko, S.O.; Lee, M.H. Surface modification of pure magnesium mesh for guided bone
regeneration: In vivo evaluation of rat calvarial defect. Materials 2019, 12, 2684. [CrossRef]
37. Chen, Y.; Ye, S.H.; Sato, H.; Zhu, Y.; Shanov, V.; Tiasha, T.; Wagner, W.R. Hybrid scaffolds of Mg alloy mesh reinforced
polymer/extracellular matrix composite for critical-sized calvarial defect reconstruction. J. Tissue Eng. Regen. Med. 2018, 12,
1374–1388. [CrossRef]
38. Brown, A.; Zaky, S.; Ray, H., Jr.; Sfeir, C. Porous magnesium/PLGA composite scaffolds for enhanced bone regeneration following
tooth extraction. Acta Biomater. 2015, 11, 543–553. [CrossRef]
39. Wang, F.; Xia, D.; Wang, S.; Gu, R.; Yang, F.; Zhao, X.; Liu, X.; Zhu, Y.; Liu, H.; Xu, Y.; et al. Photocrosslinkable Col/PCL/Mg
composite membrane providing spatiotemporal maintenance and positive osteogenetic effects during guided bone regeneration.
Bioact. Mater. 2022, 13, 53–63. [CrossRef]
40. Micic, M.; Antonijevic, D.; Milutinovic-Smiljanic, S.; Trisic, D.; Colovic, B.; Kosanovic, D.; Prokic, B.; Vasic, J.; Zivkovic, S.;
Milasin, J.; et al. Developing a novel resorptive hydroxyapatite-based bone substitute for over-critical size defect reconstruction:
Physicochemical and biological characterization and proof of concept in segmental rabbit’s ulna reconstruction. Biomed. Eng.
Biomed. Tech. 2020, 65, 491–505. [CrossRef]
41. Zhang, Y.; Lin, T.; Meng, H.; Wang, X.; Peng, H.; Liu, G.; Wei, S.; Lu, Q.; Wang, Y.; Wang, A.; et al. 3D gel-printed porous
magnesium scaffold coated with dibasic calcium phosphate dihydrate for bone repair in vivo. J. Orthop. Transl. 2022, 33, 13–23.
[CrossRef] [PubMed]
42. Xu, T.; He, X.; Chen, Z.; He, L.; Lu, M.; Ge, J.; Weng, J.; Mu, Y.; Duan, K. Effect of magnesium particle fraction on osteoinduction
of hydroxyapatite sphere-based scaffolds. J. Mater. Chem. B 2019, 7, 5648–5660. [CrossRef] [PubMed]
Molecules 2022, 27, 5529 14 of 17
43. Landi, E.; Tampieri, A.; Mattioli-Belmonte, M.; Celotti, G.; Sandri, M.; Gigante, A.; Fava, P.; Biagini, G. Biomimetic Mg- and
MgCO3 -substituted hydroxyapatites: Synthesis characterization and in vitro behaviour. J. Eur. Ceram. Soc. 2006, 26, 2593–2601.
[CrossRef]
44. Ballouze, R.; Marahat, M.H.; Mohamad, S.; Saidin, N.A.; Kasim, S.R.; Ooi, J.P. Biocompatible magnesium-doped biphasic calcium
phosphate for bone regeneration. J. Biomed. Mater. Res.-B Appl. Biomater. 2021, 109, 1426–1435. [CrossRef]
45. Sopyan, I.; Rahim, T.A. Porous magnesium-doped biphasic calcium phosphate ceramics prepared via polymeric sponge method.
Mater. Manuf. Process. 2012, 27, 702–706. [CrossRef]
46. Barallat, L.; Ruiz-Magaz, V.; Levi, P.A., Jr.; Mareque-Bueno, S.; Galindo-Moreno, P.; Nart, J. Histomorphometric results in ridge
preservation procedures comparing various graft materials in extraction sockets with nongrafted sockets in humans: A systematic
review. Implant Dent. 2014, 23, 539–554. [CrossRef]
47. Kannan, S.; Goetz-Neunhoeffer, F.; Neubauer, J.; Rebelo, A.; Valério, P.; Ferreira, J. Rietveld structure and in vitro analysis on the
influence of magnesium in biphasic (hydroxyapatite and β-tricalcium phosphate) mixtures. J. Biomed. Mater. Res. B 2009, 90,
404–411. [CrossRef]
48. Kim, D.; Shin, K.; Jung, J.S.; Chun, H.H.; Park, S.S.; Lee, J.K.; Park, H.; Yoon, S. The role of magnesium ion substituted biphasic
calcium phosphate spherical micro-scaffolds in osteogenic differentiation of human adipose tissue-derived mesenchymal stem
cells. J. Nanosci. Nanotechnol. 2015, 15, 5520–5523. [CrossRef]
49. Kim, D.J.; Kim, T.; Lee, J.D.; Shin, K.; Jung, J.S.; Hwang, K.; Lee, J.K.; Park, H.; Yoon, S. Preparation and in vitro and in vivo
performance of magnesium ion substituted biphasic calcium phosphate spherical microscaffolds as human adipose tissue-derived
mesenchymal stem cell microcarriers. J. Nanomater. 2013, 2013, 762381. [CrossRef]
50. Sartori, M.; Giavaresi, G.; Tschon, M.; Martini, L.; Dolcini, L.; Fiorini, M.; Pressato, D.; Fini, M. Long-term in vivo experimental
investigations on magnesium doped hydroxyapatite bone substitutes. J. Mater. Sci. Mater. Med. 2014, 25, 1495–1504. [CrossRef]
51. Santos, G.G.; Nunes, V.L.C.; Marinho, S.M.O.C.; Santos, S.R.A.; Rossi, A.M.; Miguel, F.B. Biological behavior of magnesium-
substituted hydroxyapatite during bone repair. Braz. J. Biol. 2021, 81, 53–61. [CrossRef] [PubMed]
52. Grigolato, R.; Pizzi, N.; Brotto, M.C.; Corrocher, G.; Desando, G.; Grigolo, B. Magnesium-enriched hydroxyapatite as bone filler in
an ameloblastoma mandibular defect. Int. J. Clin. Exp. Med. 2015, 8, 281–288. [PubMed]
53. Horowitz, R.; Holtzclaw, D.; Rosen, P.S. A review on alveolar ridge preservation following tooth extraction. J. Evid. Based Dent.
Pract. 2012, 12, 149–160. [CrossRef]
54. Canullo, L.; Sisti, A. Early implant loading after vertical ridge augmentation (VRA) using e-PTFE titanium-reinforced membrane
and nano-structured hydroxyapatite: 2-year prospective study. Eur. J. Oral Implantol. 2010, 3, 59–69. [PubMed]
55. Crespi, R.; Capparè, P.; Gherlone, E. Comparison of magnesium-enriched hydroxyapatite and porcine bone in human extraction
socket healing: A histologic and histomorphometric evaluation. Int. J. Oral Maxillofac. Implants 2011, 26, 1057–1062. [PubMed]
56. Crespi, R.; Capparè, P.; Gherlone, E. Magnesium-enriched hydroxyapatite compared to calcium sulfate in the healing of human
extraction sockets: Radiographic and histomorphometric evaluation at 3 months. J. Periodontol. 2009, 80, 210–218. [CrossRef]
57. Caneva, M.; Botticelli, D.; Stellini, E.; Souza, S.L.S.; Salata, L.A.; Lang, N.P. Magnesium-enriched hydroxyapatite at immediate
implants: A histomorphometric study in dogs. Clin. Oral Implants Res. 2010, 22, 512–517. [CrossRef]
58. Taschieri, S.; Del Fabbro, M.; Panda, S.; Goker, F.; Babina, K.S.; Tampieri, A.; Mortellaro, C. Prospective clinical and histologic
evaluation of alveolar socket healing following ridge preservation using a combination of hydroxyapatite and collagen biomimetic
xenograft versus demineralized bovine bone. J. Craniofac. Surg. 2019, 30, 1089–1094. [CrossRef]
59. Crespi, R.; Mariani, E.; Benasciutti, E.; Capparè, P.; Cenci, S.; Gherlone, E. Magnesium-enriched hydroxyapatite versus autologous
bone in maxillary sinus grafting: Combining histomorphometry with osteoblast gene expression profiles ex vivo. J. Periodontol.
2009, 80, 586–593. [CrossRef]
60. Radetić, A.T.J.; Cvek, S.Z.; Tomas, M.; Erjavec, I.; Oguić, M.; Kačarević, Ž.P.; Peloza, O.C. CSBD healing in rats after application of
bovine xenogeneic biomaterial enriched with magnesium alloy. Int. J. Mol. Sci. 2021, 22, 9089. [CrossRef]
61. Park, J.W.; Ko, H.J.; Jang, J.H.; Kang, H.; Suh, J.Y. Increased new bone formation with a surface magnesium-incorporated
deproteinized porcine bone substitute in rabbit calvarial defects. J. Biomed. Mater. Res. 2012, 100, 834–840. [CrossRef] [PubMed]
62. Roller, B.L.; Kuroki, K.; Bozynski, C.C.; Pfeiffer, F.M.; Cook, J.L. Use of a novel magnesium-based resorbable bone cement for
augmenting anchor and tendon fixation. Am. J. Orthoped. 2018, 47. [CrossRef] [PubMed]
63. Sehlke, B.M.; Wilson, T.G.; Jones, A.A.; Yamashita, M.; Cochran, D.L. The use of a magnesium-based bone cement to secure
immediate dental implants. Int. J. Oral Maxillofac. Implants 2013, 28, e357–e367. [CrossRef] [PubMed]
64. Guan, X.; Xiong, M.; Zeng, F.; Xu, B.; Yang, L.; Guo, H.; Niu, J.; Zhang, J.; Chen, C.; Pei, J.; et al. Enhancement of osteogenesis and
biodegradation control by brushite coating on Mg-Nd-Zn-Zr alloy for mandibular bone repair. ACS Appl. Mater. Interfaces 2014, 6,
21525–21533. [CrossRef]
65. Almehmadi, A. Effect of magnesium-based coatings on titanium or zirconia substrates on bone regeneration and implant—A
systematic review. Front. Mater. 2021, 8, 754697. [CrossRef]
66. Stanford, C. Surface modifications of dental implants. Aust. Dent. J. 2008, 53, S26–S33. [CrossRef]
67. Lung, C.Y.K.; Matinlinna, J.P. Aspects of silane coupling agents and surface conditioning in dentistry: An overview. Dent. Mater.
2012, 28, 467–477. [CrossRef]
68. Yu, Y.; Jin, G.; Xue, Y.; Wang, D.; Liu, X.; Sun, J. Multifunctions of dual Zn/Mg ion co-implanted titanium on osteogenesis,
angiogenesis and bacteria inhibition for dental implants. Acta Biomater. 2017, 49, 590–603. [CrossRef]
Molecules 2022, 27, 5529 15 of 17
69. Xie, Y.; Zhai, W.; Chen, L.; Chang, J.; Zheng, X.; Ding, C. Preparation and in vitro evaluation of plasma-sprayed Mg2 SiO4 coating
on titanium alloy. Acta Biomater. 2009, 5, 2331–2337. [CrossRef]
70. Won, S.; Huh, Y.H.; Cho, L.R.; Lee, H.S.; Byon, E.S.; Park, C.J. Cellular response of human bone marrow derived mesenchymal
stem cells to titanium surfaces implanted with calcium and magnesium ions. Tissue Eng. Regen. Med. 2017, 14, 123–131. [CrossRef]
71. Onder, S.; Calikoglu-Koyuncu, A.C.; Kazmanli, K.; Urgen, M.; Kok, F.N.; Torun-Kose, G. Magnesium doping on TiN coatings
affects mesenchymal stem cell differentiation and proliferation positively in a dose-dependent manner. Biomed. Mater. Eng. 2018,
29, 427–438. [CrossRef] [PubMed]
72. Mihailescu, N.; Stan, G.E.; Duta, L.; Chifiriuc, M.C.; Bleotu, C.; Sopronyi, M.; Luculescu, C.; Oktar, F.N.; Mihailescu, I.N. Structural,
compositional, mechanical characterization and biological assessment of bovine-derived hydroxyapatite coatings reinforced with
MgF2 or MgO for implants functionalization. Mater. Sci. Eng. C 2016, 59, 863–874. [CrossRef] [PubMed]
73. Jiang, X.; Wang, G.; Li, J.; Zhang, W.; Xu, L.; Pan, H.; Wen, J.; Wu, Q.; She, W.; Jiao, T.; et al. Magnesium ion implantation on a
micro/nanostructured titanium surface promotes its bioactivity and osteogenic differentiation function. Int. J. Nanomed. 2014, 8,
2387–2398. [CrossRef] [PubMed]
74. Park, K.D.; Lee, B.A.; Piao, X.H.; Lee, K.K.; Park, S.W.; Oh, H.K.; Young, J.K.; Hong, J.P. Effect of magnesium and calcium
phosphate coatings on osteoblastic responses to the titanium surface. J. Adv. Prosthodont. 2013, 5, 402–408. [CrossRef] [PubMed]
75. Cho, L.R.; Kim, D.G.; Kim, J.H.; Byon, E.S.; Jeong, Y.S.; Park, C.J. Bone response of mg ion-implanted clinical implants with the
plasma source ion implantation method. Clin. Oral Implants Res. 2010, 21, 848–856. [CrossRef] [PubMed]
76. Li, X.; Li, Y.; Liao, Y.; Li, J.; Zhang, L.; Hu, J. The effect of magnesium incorporated hydroxyapatite coating on titanium implant
fixation in ovariectomized rats. Int. J. Oral Maxillofac. Implants 2014, 29, 196–202. [CrossRef] [PubMed]
77. Tao, Z.S.; Zhou, W.S.; He, X.W.; Liu, W.; Bai, B.L.; Zhou, Q.; Huang, Z.L.; Tu, K.K.; Li, H.; Sun, T.; et al. A comparative study of
zinc, magnesium, strontium-incorporated hydroxyapatite-coated titanium implants for osseointegration of osteopenic rats. Mater.
Sci. Eng. C 2016, 62, 226–232. [CrossRef]
78. Zhao, S.F.; Jiang, Q.H.; Peel, S.; Wang, X.X.; He, F.M. Effects of magnesium-substituted nanohydroxyapatite coating on implant
osseointegration. Clin. Oral Implant. Res. 2013, 24, 34–41. [CrossRef]
79. Esmaily, M.; Svensson, J.E.; Fajardo, S.; Birbilis, N.; Frankel, G.S.; Virtanen, S.; Arrabal, R.; Thomas, S.; Johansson, L.G.
Fundamentals and advances in magnesium alloy corrosion. Prog. Mater. Sci. 2017, 89, 92–193. [CrossRef]
80. Liu, Y.; Wang, D.L.; Huang, Y.C.; Wang, T.B.; Zeng, H. Hydrogen inhibits the osteoclastogenesis of mouse bone marrow
mononuclear cells. Mater. Sci. Eng. C 2020, 110, 110640. [CrossRef]
81. Mraied, H.; Wang, W.; Cai, W. Influence of chemical heterogeneity and microstructure on the corrosion resistance of biodegradable
WE43 magnesium alloys. J. Mater. Chem. B 2019, 7, 6399–6411. [CrossRef] [PubMed]
82. Wang, Q.; Tan, L.; Xu, W.; Zhang, B.; Yang, K. Dynamic behaviors of a Ca–P coated AZ31B magnesium alloy during in vitro and
in vivo degradations. Mater. Sci. Eng. B 2011, 176, 1718–1726. [CrossRef]
83. Pogorielov, M.; Husak, E.; Solodivnik, A.; Zhdanov, S. Magnesium-based biodegradable alloys: Degradation, application, and
alloying elements. Interv. Med. Appl. Sci. 2017, 9, 27–38. [CrossRef] [PubMed]
84. Han, P.; Cheng, P.; Zhang, S.; Zhao, C.; Ni, J.; Zhang, Y.; Zhong, W.; Hou, P.; Zhang, X.; Zheng, Y.; et al. In vitro and in vivo
studies on the degradation of high-purity Mg (99.99 wt.%) screw with femoral intracondylar fractured rabbit model. Biomaterials
2015, 64, 57–69. [CrossRef]
85. Bonithon, R.; Kao, A.P.; Fernández, M.P.; Dunlop, J.N.; Blunn, G.W.; Witte, F.; Tozzi, G. Multi-scale mechanical and morphological
characterisation of sintered porous magnesium-based scaffolds for bone regeneration in critical-sized defects. Acta Biomater. 2021,
127, 338–352. [CrossRef]
86. Chen, Q.; Thouas, G.A. Metallic implant biomaterials. Mater. Sci. Eng. R Rep. 2015, 87, 1–57. [CrossRef]
87. Witte, F.; Kaese, V.; Haferkamp, H.; Switzer, E.; Meyer-Lindenberg, A.; Wirth, C.J.; Windhagen, H. In vivo corrosion of four
magnesium alloys and the associated bone response. Biomaterials 2005, 26, 3557–3563. [CrossRef]
88. Chen, K.; Lu, Y.; Tang, H.; Gao, Y.; Zhao, F.; Gu, X.; Fan, Y. Effect of strain on degradation behaviors of WE43, Fe and Zn wires.
Acta Biomater. 2020, 113, 627–645. [CrossRef]
89. Mao, L.; Shen, L.; Chen, J.; Wu, Y.; Kwak, M.; Lu, Y.; Xue, Q.; Pei, J.; Zhang, L.; Yuan, G.; et al. Enhanced bioactivity of
Mg-Nd-Zn-Zr alloy achieved with nanoscale MgF2 surface for vascular stent application. ACS Appl. Mater. Interfaces 2015, 7,
5320–5330. [CrossRef]
90. Holweg, P.; Herber, V.; Ornig, M.; Hohenberger, G.; Donohue, N.; Puchwein, P.; Leithner, A.; Seibert, F. A lean magnesium–
zinc–calcium alloy ZX00 used for bone fracture stabilization in a large growing animal model. Acta Biomater. 2020, 113, 646–659.
[CrossRef]
91. Zhao, D.; Huang, S.; Lu, F.; Wang, B.; Yang, L.; Qin, L.; Yang, K.; Li, Y.; Li, W.; Wang, W.; et al. Vascularized bone grafting fixed by
biodegradable magnesium screw for treating osteonecrosis of the femoral head. Biomaterials 2016, 81, 84–92. [CrossRef] [PubMed]
92. Plaass, C.; von Falck, C.; Ettinger, S.; Sonnow, L.; Calderone, F.; Weizbauer, A.; Reifenrath, J.; Claassen, L.; Waizy, H.;
Daniilidis, K.; et al. Bioabsorbable magnesium versus standard titanium compression screws for fixation of distal metatarsal
osteotomies—3 year results of a randomized clinical trial. J. Orthop. Sci. 2018, 23, 321–327. [CrossRef] [PubMed]
93. Acar, B.; Kose, O.; Turan, A.; Unal, M.; Kati, Y.A.; Guler, F. Comparison of bioabsorbable magnesium versus titanium screw
fixation for modified distal chevron osteotomy in hallux valgus. Biomed. Res. Int. 2018, 2018, 5242808. [CrossRef] [PubMed]
Molecules 2022, 27, 5529 16 of 17
94. Klauser, H. Internal fixation of three-dimensional distal metatarsal i osteotomies in the treatment of hallux valgus deformities
using biodegradable magnesium screws in comparison to titanium screws. Foot Ankle Surg. 2019, 25, 398–405. [CrossRef]
[PubMed]
95. Atkinson, H.D.; Khan, S.; Lashgari, Y.; Ziegler, A. Hallux valgus correction utilising a modified short scarf osteotomy with a
magnesium biodegradable or titanium compression screws—A comparative study of clinical outcomes. BMC Musculoskelet.
Disord. 2019, 20, 334. [CrossRef] [PubMed]
96. Sukotjo, C.; Lima-Neto, T.J.; Júnior, J.F.S.; Faverani, L.P.; Miloro, M. Is there a role for absorbable metals in surgery? A systematic
review and meta-analysis of Mg/Mg alloy based implants. Materials 2020, 13, 3914. [CrossRef]
97. Zhang, X.; Yuan, G.; Mao, L.; Niu, J.; Fu, P.; Ding, W. Effects of extrusion and heat treatment on the mechanical properties and
biocorrosion behaviors of a Mg-Nd-Zn-Zr alloy. J. Mech. Behav. Biomed. Mater. 2012, 7, 77–86. [CrossRef]
98. Gareb, B.; van Bakelen, N.B.; Buijs, G.J.; Jansma, J.; de Visscher, J.; Hoppenreijs, T.J.M.; Bergsma, J.E.; van Minnen, B.; Stegenga, B.;
Bos, R.R.M. Comparison of the long-term clinical performance of a biodegradable and a titanium fixation system in maxillofacial
surgery: A multicenter randomized controlled trial. PLoS ONE 2017, 12, e0177152. [CrossRef]
99. Henderson, S.E.; Verdelis, K.; Maiti, S.; Pal, S.; Chung, W.L.; Chou, D.T.; Kumta, P.N.; Almarza, A.J. Magnesium alloys as a
biomaterial for degradable craniofacial screws. Acta Biomater. 2014, 10, 2323–23320. [CrossRef]
100. Lee, J.Y.; Lee, J.W.; Pang, K.M.; Kim, H.E.; Kim, S.M.; Lee, J.H. Biomechanical evaluation of magnesium-based resorbable metallic
screw system in a bilateral sagittal split ramus osteotomy model using three-dimensional finite element analysis. J. Oral Maxillofac.
Surg. 2014, 72, 402. [CrossRef]
101. Lee, J.H.; Han, H.S.; Kim, Y.C.; Lee, J.Y.; Lee, B.K. Stability of biodegradable metal (Mg-Ca-Zn alloy) screws compared with
absorbable polymer and titanium screws for sagittal split ramus osteotomy of the mandible using the finite element analysis
model. J. Cranio-Maxillofac. Surg. 2017, 45, 1639–1646. [CrossRef] [PubMed]
102. Schaller, B.; Saulacic, N.; Beck, S.; Imwinkelried, T.; Goh, B.T.; Nakahara, K.; Hofstetter, W.; Iizuka, T. In vivo degradation of a
new concept of magnesium-based rivet-screws in the minipig mandibular bone. Mater. Sci. Eng. C Mater. Biol. Appl. 2016, 69,
247–254. [CrossRef] [PubMed]
103. Naujokat, H.; Ruff, C.B.; Kluter, T.; Seitz, J.M.; Acil, Y.; Wiltfang, J. Influence of surface modifications on the degradation of
standard-sized magnesium plates and healing of mandibular osteotomies in miniature pigs. Int. J. Oral Maxillofac. Surg. 2020, 49,
272–283. [CrossRef] [PubMed]
104. Byun, S.H.; Lim, H.K.; Cheon, K.H.; Lee, S.M.; Kim, H.E.; Lee, J.H. Biodegradable magnesium alloy (WE43) in bone-fixation plate
and screw. J. Biomed. Mater. Res. B Appl. Biomater. 2020, 108, 2505–2512. [CrossRef]
105. Byun, S.H.; Lim, H.K.; Lee, S.M.; Kim, H.J.; Kim, S.M.; Lee, J. Biodegradable magnesium alloy (ZK60) with a poly(l-lactic)-acid
polymer coating for maxillofacial surgery. Metals 2020, 10, 724. [CrossRef]
106. Schaller, B.; Burkhard, J.P.M.; Chagnon, M.; Beck, S.; Imwinkelried, T.; Assad, M. Fracture healing and bone remodeling with hu-
man standard-sized magnesium versus polylactide-Co-glycolide plate and screw systems using a mini-swine craniomaxillofacial
osteotomy fixation model. J. Oral Maxillofac. Surg. 2018, 76, 2138–2150. [CrossRef]
107. Kim, B.J.; Piao, Y.; Wufuer, M.; Son, W.C.; Choi, T.H. Biocompatibility and efficiency of biodegradable magnesium-based plates
and screws in the facial fracture model of beagles. J. Oral Maxillofac. Surg. 2018, 76, 1055. [CrossRef]
108. Naujokat, H.; Seitz, J.M.; Acil, Y.; Damm, T.; Moller, I.; Gulses, A.; Wiltfang, J. Osteosynthesis of a cranio-osteoplasty with a
biodegradable magnesium plate system in miniature pigs. Acta Biomater. 2017, 62, 434–445. [CrossRef]
109. Schaller, B.; Saulacic, N.; Imwinkelried, T.; Beck, S.; Liu, E.W.; Gralla, J.; Nakahara, K.; Hofstetter, W.; Iizuka, T. In vivo degradation
of magnesium plate/screw osteosynthesis implant systems: Soft and hard tissue response in a calvarial model in miniature pigs.
J. Cranio-Maxillofac. Surg. 2016, 44, 309–317. [CrossRef]
110. Zhang, D.; Ni, N.; Su, Y.; Miao, H.; Tang, Z.; Ji, Y.; Wang, Y.; Gao, H.; Ju, Y.; Sun, N.; et al. Targeting local osteogenic and
ancillary cells by mechanobiologically optimized magnesium scaffolds for orbital bone reconstruction in canines. ACS Appl.
Mater. Interfaces 2020, 12, 27889–27904. [CrossRef]
111. Leonhardt, H.; Franke, A.; McLeod, N.M.H.; Lauer, G.; Nowak, A. Fixation of fractures of the condylar head of the mandible with
a new magnesium-alloy biodegradable cannulated headless bone screw. Br. J. Oral Maxillofac. Surg. 2017, 55, 623–625. [CrossRef]
[PubMed]
112. Leonhardt, H.; Ziegler, A.; Lauer, G.; Franke, A. Osteosynthesis of the mandibular condyle with magnesium-based biodegradable.
Headless compression screws show good clinical results during a 1-year follow-up period. J. Oral Maxillofac. Surg. 2021, 79,
637–643. [CrossRef] [PubMed]
113. Laiteerapong, A.; Lochaiwatana, Y.; Hirata, I.; Okazaki, M.; Mori, K.; Murakami, S.; Poolthong, S. A novel glass ionomer cement
containing MgCO3 apatite induced the increased proliferation and differentiation of human pulp cells in vitro. Dent. Mater. J.
2012, 31, 772–778. [CrossRef] [PubMed]
114. Kong, Y.; Hu, X.; Zhong, Y.; Xu, K.; Wu, B.; Zheng, J. Magnesium-enriched microenvironment promotes odontogenic dif-
ferentiation in human dental pulp stem cells by activating ERK/BMP2/Smads signaling. Stem Cell Res. Ther. 2019, 10, 378.
[CrossRef]
115. Zheng, J.M.; Kong, Y.Y.; Li, Y.Y.; Zhang, W. MagT1 regulated the odontogenic differentiation of BMMSCs induced by TGC-CM
via ERK signaling pathway. Stem Cell Res. Ther. 2019, 10, 48. [CrossRef]
Molecules 2022, 27, 5529 17 of 17
116. Lange, T.S.; Kirchberg, J.; Bielinsky, A.K.; Leuker, A.; Bank, L.; Ruzicka, T.; Scharffetter-Kochanek, K. Divalent cations (Mg2+ ,
Ca2+ ) differentially influence the β1 integrin-mediated migration of human fibroblasts and keratinocytes to different extracellular
matrix proteins. Exp. Dermatol. 1995, 4, 130–137. [CrossRef]
117. Lange, T.S.; Bielinsky, A.K.; Kirchberg, K.; Bank, I.; Herrmann, K.; Krieg, T.; Scharffetter-Kochanek, K. Mg2+ and Ca2+ differentially
regulate β1 integrinmediated adhesion of dermal fibroblasts and keratinocytes to various extracellular matrix proteins. Exp. Cell
Res. 1994, 214, 381–388. [CrossRef]
118. Heitz-Mayfield, L.J.; Lang, N.P. Comparative biology of chronic and aggressive periodontitis vs. peri-implantitis. Periodontol.
2000 2010, 53, 167–181. [CrossRef]
119. Takamori, Y.; Atsuta, I.; Nakamura, H.; Sawase, T.; Koyano, K.; Hara, Y. Histopathological comparison of the onset of peri-
implantitis and periodontitis in rats. Clin. Oral Implants Res. 2017, 28, 163–170. [CrossRef]
120. Okawachi, H.; Ayukawa, Y.; Atsuta, I.; Furuhashi, A.; Sakaguchi, M.; Yamane, K.; Koyano, K. Effect of titanium surface calcium
and magnesium on adhesive activity of epithelial-like cells and fibroblasts. Biointerphases 2012, 7, 27. [CrossRef]
121. Diekmann, J.; Bauer, S.; Weizbauer, A.; Willbold, E.; Windhagen, H.; Helmecke, P.; Lucas, A.; Reifenrath, J.; Nolte, L.; Ezechieli, M.
Examination of a biodegradable magnesium screw for the reconstruction of the anterior cruciate ligament: A pilot in vivo study
in rabbits. Mater. Sci. Eng. C Mater. Biol. Appl. 2016, 59, 1100–1109. [CrossRef]
122. Fu, Y.M.; Yin, Y.; Guan, J.W.; Ji, Q.B.; Wang, Y.; Zhang, Q. The evaluation of a degradable magnesium alloy bio-transfix nail
system compounded with bone morphogenetic protein-2 in a beagle anterior cruciate ligament reconstruction model. J. Biomater.
Appl. 2019, 34, 687–698. [CrossRef] [PubMed]
123. Wang, J.; Xu, J.; Fu, W.; Cheng, W.; Chan, K.; Yung, P.S.; Qin, L. Biodegradable magnesium screws accelerate fibrous tissue
mineralization at the tendon-bone insertion in anterior cruciate ligament reconstruction model of rabbit. Sci. Rep. 2017, 7, 40369.
[CrossRef] [PubMed]
124. Kirkland, A.E.; Sarlo, G.L.; Holton, K.F. The role of magnesium in neurological disorders. Nutrients 2018, 10, 730. [CrossRef]
125. Fei, J.; Wen, X.; Lin, X.; Saijilafu; Wang, W.; Ren, O.; Chen, X.; Tan, L.; Yang, K.; Yang, H.; et al. Biocompatibility and neurotoxicity
of magnesium alloys potentially used for neural repairs. Mater. Sci. Eng. C 2017, 78, 1155–1163. [CrossRef]
126. Chen, Y.J.; Cheng, F.C.; Chen, C.J.; Su, H.L.; Sheu, M.L.; Sheehan, J.; Pan, H.C. Downregulated expression of magnesium
transporter genes following a high magnesium diet attenuates sciatic nerve crush injury. Neurosurgery 2019, 84, 965–976.
[CrossRef]
127. Sheldon, A.; Aleman, M.; Costa, L.R.R.; Weich, K.; Howey, Q.; Madigan, J.E. Effects of magnesium with or without boron on
headshaking behavior in horses with trigeminal-mediated headshaking. J. Vet. Intern. Med. 2019, 33, 1464–1472. [CrossRef]
128. Jamshidi, A.; Hasanzadeh, A.; Zonnour, A.; Dabiri, S.; Yazdani, N. Iatrogenic facial nerve injury in mastoidectomy: The impact of
variables on the outcome. Am. J. Otolaryngol. 2022, 43, 103472. [CrossRef]
129. Gougoulias, N.; Hatzisotiriou, A.; Kapoukranidou, D.; Albani, M. Magnesium administration provokes motor unit survival, after
sciatic nerve injury in neonatal rats. BMC Musculoskelet. Disord. 2004, 5, 33. [CrossRef]
130. Vennemeyer, J.J.; Hopkins, T.; Kuhlmann, J.; Heineman, W.R.; Pixley, S.K. Effects of elevated magnesium and substrate on
neuronal numbers and neurite outgrowth of neural stem/progenitor cells in vitro. Neurosci. Res. 2014, 84, 72–78. [CrossRef]